CJC-1295 With DAC 10mg Research Compound

CJC-1295 with DAC is a research peptide studied for its ability to
activate growth hormone-releasing hormone (GHRH) receptors. These
receptors are part of the biological signaling system that controls
the release of growth hormone and influences downstream IGF-1
signaling.

The DAC portion is what makes this version of CJC-1295 different.
DAC stands for Drug Affinity Complex and is designed
to extend how long the peptide remains active in experimental models.
This allows researchers to study longer-lasting GHRH receptor signaling
rather than only short-duration signaling.

Commonly Researched For

• Growth hormone-releasing hormone (GHRH) receptor signaling
• Growth hormone and IGF-1 signaling pathways
• Long-duration growth hormone signaling models
• Metabolism and body-composition research
• Muscle and tissue maintenance pathways
• Recovery-related biological signaling
• Endocrine and hormone-signaling research
• Differences between short- and long-acting GHRH signaling

About CJC-1295 With DAC Research

Growth hormone production is controlled by a network of hormonal
signals. One of those signals is growth hormone-releasing hormone,
or GHRH. CJC-1295 is designed to interact with the GHRH receptor,
allowing researchers to study what happens when this signaling
pathway is activated.

Researchers examine this pathway because growth hormone signaling
is connected to several biological processes, including cellular
growth, metabolism, tissue maintenance, and the production of
insulin-like growth factor 1 (IGF-1).

The defining feature of CJC-1295 with DAC is its extended activity.
The Drug Affinity Complex allows the research peptide to associate
with albumin in experimental systems, which can prolong its presence
compared with shorter-acting GHRH-related research peptides.

This makes CJC-1295 with DAC particularly useful for research models
examining sustained GHRH receptor activation and longer-duration
changes in growth hormone and IGF-1 signaling.

Researchers may also investigate downstream pathways related to
metabolism, body composition, tissue maintenance, and recovery to
better understand how prolonged growth hormone signaling affects
these biological systems.

In simple terms, CJC-1295 with DAC research focuses on understanding
how longer-lasting stimulation of the body's growth hormone signaling
system affects hormone communication, metabolism, cellular activity,
and related biological pathways.

Product Details

• Compound: CJC-1295 with DAC
• Total compound: 10mg
• Format: Lyophilized powder
• Primary research pathway: GHRH receptor signaling
• Intended use: Laboratory research only
• Application: Analytical and in-vitro research